Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and com... Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. It is advancing a deep and sustainable product portfolio of 18 gene therapy product candidates, with exclusive options to acquire four additional development programs. Its product candidates include TSHA-101, TSHA-118, TSHA-102, TSHA-103, and TSHA-104. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.15 | 9.375 | 1.6 | 1.77 | 1.57 | 1671596 | 1.66435692 | CS |
| 4 | 0 | 0 | 1.75 | 1.885 | 1.46 | 1780262 | 1.65458106 | CS |
| 12 | -0.28 | -13.7931034483 | 2.03 | 2.125 | 1.435 | 2102528 | 1.70722144 | CS |
| 26 | -0.53 | -23.2456140351 | 2.28 | 3.31 | 1.19 | 3175499 | 2.02250536 | CS |
| 52 | -0.73 | -29.435483871 | 2.48 | 4.32 | 1.19 | 2782651 | 2.32547383 | CS |
| 156 | -4.58 | -72.3538704581 | 6.33 | 7.0774 | 0.5 | 1989192 | 2.30332606 | CS |
| 260 | -20.5 | -92.1348314607 | 22.25 | 33.84 | 0.5 | 1383035 | 2.90925136 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
